[PCRX] YoY Quarter Result on 31-Dec-2016 [#Q4]

Stock
[PCRX] Pacira BioSciences, Inc.
Announcement Date
01-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- 82.07%
YoY- -59.05%
Quarter Report
PCRX's Result
PCRX's Financial Summary
View:
Show?
Quarter Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 122,424 95,115 79,078 72,902 69,320 61,793 33,565 24.05%
PBT -3,541 8,322 4,630 -3,994 -2,606 5,975 -11,956 -18.34%
Tax 1,347 37 35 -21 -108 173 1,911 -5.65%
NP -4,888 8,285 4,595 -3,973 -2,498 5,802 -11,956 -13.84%
Tax Rate - -0.44% -0.76% - - -2.90% - -
Total Cost 127,312 86,830 74,483 76,875 71,818 55,991 45,521 18.68%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin -3.99 8.71 5.81 -5.45 -3.60 9.39 -35.62 -30.55%
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS -0.12 0.20 0.11 -0.11 -0.07 0.16 -0.36 -16.72%
EPS Diluted -0.12 0.20 0.11 -0.11 -0.07 0.14 -0.35 -16.33%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.